Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

ArcherDX

Biotech & Life Sciences · Boulder, United States · Founded 2013 Unicorn

Biotechnology firm specializing in cancer research

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

7 investors on ArcherDX's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage
PBM Capital Group
Boulder Ventures
Series B+ 5 investors entered at this stage
Driehaus Capital Management
Perceptive Advisors
The Peierls Foundation
ArrowMark Partners
Redmile Group

Global footprint

Where ArcherDX has talent and traffic

Workforce by country
🇺🇸 United States · Boulder HQ
Book a demo for the full country breakdown
Web traffic by country
3.2K monthly visits
across markets
🇺🇸 United States96.9%
🇫🇷 France0%
Top 2 markets shown

Patent intelligence

$25M patent portfolio · 11 active families

Estimated portfolio value
$25M
1.8% of valuation · 9.9× smaller than top peer Arrowhead Pharmaceuticals ($246M)
11 active patent families
Where ArcherDX innovates Nucleic acidGenome sequence analysisSequence analysisMolecular biologyBioinformatics

Where ArcherDX concentrates vs peers

Each axis is a top-10 topic across ArcherDX and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about ArcherDX

An AI-synthesized read of the highest-engagement posts about ArcherDX on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ArcherDX on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.